Tris Pharma, Inc., a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, has appointed Franchesca Fowler, JD, as chief compliance officer and vice president, general counsel. Ms. Fowler will oversee all legal matters within the company, including legal compliance, IP management, litigation and more.   Ms. Fowler brings 15 years of experience, most recently serving as the head of legal and compliance,...